Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 8/20 | 0.59 |
| ▸ | MAPT | P10636 | 4/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.59 |
| ▸ | MEN1 | O00255 | 2/20 | 0.59 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.56 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.55 |
| ▸ | NSD2 | O96028 | 1/20 | 0.55 |
| ▸ | ESR1 | P03372 | 3/20 | 0.53 |
| ▸ | ESR2 | Q92731 | 3/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.51 |
| ▸ | PKM | P14618 | 1/20 | 0.51 |
| ▸ | F2 | P00734 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | RAB9A | P51151 | 1/20 | 0.49 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.49 |
| ▸ | ACR | P10323 | 1/20 | 0.49 |
| ▸ | TMPRSS15 | P98073 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | CA12 | O43570 | 2/20 | 0.47 |
| ▸ | CA9 | Q16790 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17383940 | 0.96 | KMT2A (0.59) | KMT2AMAPTTDP1MEN1L3MBTL1 | |
| SCHEMBL23212138 | 0.88 | EGFR (0.53) | KMT2AMAPTTDP1MEN1L3MBTL1 | |
| SCHEMBL17376972 | 0.88 | MAPT (0.53) | KMT2AMAPTTDP1MEN1L3MBTL1 | |
| SCHEMBL2755026 | 0.87 | KMT2A (0.68) | KMT2AMAPTTDP1MEN1L3MBTL1 | |
| SCHEMBL9299759 | 0.86 | NSD2 (0.73) | KMT2AMAPTTDP1MEN1L3MBTL1 | |
| SCHEMBL8205792 | 0.86 | CA12 (0.52) | KMT2AMAPTTDP1MEN1ESR1 | |
| SCHEMBL321816 | 0.85 | TSHR (0.59) | KMT2AMAPTTDP1MEN1L3MBTL1 | |
| Benzoic Acid 3-Hydroxyphenyl Ester SCHEMBL78117 | 0.85 | ESR1 (0.71) | KMT2AMAPTTDP1MEN1L3MBTL1 | |
| Benzoic Acid 3-Hydroxyphenyl Ester SCHEMBL31650796 | 0.85 | ESR1 (0.71) | KMT2AMAPTTDP1MEN1L3MBTL1 | |
| SCHEMBL10960406 | 0.84 | NSD2 (0.70) | KMT2AMAPTTDP1MEN1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3161063-B1 | STABILIZED MOISTURE-CURABLE POLYMERIC COMPOSITIONS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2024-03-06 | — | — | EP | claimed |
| US-10100181-B2 | Stabilized moisture-curable polymeric compositions | DOW GLOBAL TECHNOLOGIES LLC (US) | 2018-10-16 | — | — | US | claimed |
| US-20170210892-A1 | STABILIZED MOISTURE-CURABLE POLYMERIC COMPOSITIONS | DOW GLOBAL TECHNOLOGIES LLC | 2017-07-27 | — | — | US | claimed |
| EP-3161063-A1 | STABILIZED MOISTURE-CURABLE POLYMERIC COMPOSITIONS | Dow Global Technologies LLC (US) | 2017-05-03 | — | — | EP | claimed |
| WO-2015200016-A1 | STABILIZED MOISTURE-CURABLE POLYMERIC COMPOSITIONS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2015-12-30 | — | — | WO | claimed |
| US-20140194499-A1 | Polyprenylated Benzoylphloroglucinols With Anticancer Activity | HONG KONG BAPTIST UNIVERSITY (HK) | 2014-07-10 | — | — | US | claimed |
| US-12521410-B2 | Compounds and pharmaceutical uses thereof | SYNEURX INTERNATIONAL (TAIWAN) CORP. (TW) | 2026-01-13 | — | — | US | disclosed |
| US-20240180945-A1 | COMPOUNDS AND PHARMACEUTICAL USES THEREOF | SYNEURX INTERNATIONAL (TAIWAN) CORP. (TW) | 2024-06-06 | — | — | US | disclosed |
| EP-3161063-B1 | STABILIZED MOISTURE-CURABLE POLYMERIC COMPOSITIONS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2024-03-06 | — | — | EP | disclosed |
| US-11793823-B2 | Compounds and pharmaceutical uses thereof | SYNEURX INTERNATIONAL (TAIWAN) CORP. (TW) | 2023-10-24 | — | — | US | disclosed |
| US-11793823-B2 | Compounds and pharmaceutical uses thereof | SYNEURX INTERNATIONAL (TAIWAN) CORP. (TW) | 2023-10-24 | — | — | US | disclosed |
| US-11793823-B2 | Compounds and pharmaceutical uses thereof | SYNEURX INTERNATIONAL (TAIWAN) CORP. (TW) | 2023-10-24 | — | — | US | disclosed |
| CN-115836062-A | Compound and medical application thereof | 心悦生医股份有限公司 | 2023-03-21 | — | — | CN | disclosed |
| WO-2006081537-A2 | NOVEL AROMATIC PRENYLTRANSFERASES, NUCLEIC ACIDS ENCODING SAME AND USES THEREFOR | THE SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) | 2006-08-03 | — | — | WO | disclosed |
| EP-0549339-B1 | Photosensitive composition | MITSUBISHI CHEM CORP (JP) | 1997-05-14 | — | — | EP | disclosed |
| US-5338643-A | O-quinonediazide photosensitive composition containing s-triazine compound, novolak resin, vinyl-based polymer and a dye | MITSUBISHI KASEI CORPORATION (JP) | 1994-08-16 | — | — | US | disclosed |
| EP-0549339-A1 | Photosensitive composition | Mitsubishi Chemical Corporation (JP) | 1993-06-30 | — | — | EP | disclosed |
| US-4202833-A | INTERMEDIATES TO BISPHENOL CARBONATES | THE UPJOHN COMPANY (US) | 1980-05-13 | — | — | US | disclosed |
| US-4200763-A | CHEMICAL INTERMEDIATE | THE UPJOHN COMPANY (US) | 1980-04-29 | — | — | US | disclosed |
| US-4164510-A | METAL PHTHALOCYANINE, TERT-ALKYL PEROXIDE AS CATALYST | THE UPJOHN COMPANY (US) | 1979-08-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140194499-A1 | Polyprenylated Benzoylphloroglucinols With Anticancer Activity | NUDC, PGC, GANC | KMT2A 2825/4885MAPT 4628/4885TDP1 2146/4885 |
| US-11793823-B2 | Compounds and pharmaceutical uses thereof | HRH4, OR10J3, CYP3A5 | KMT2A 4419/4885MAPT 2751/4885TDP1 4760/4885 |
| US-20240180945-A1 | COMPOUNDS AND PHARMACEUTICAL USES THEREOF | HRH4, OR10J3, CYP3A5 | KMT2A 4419/4885MAPT 2751/4885TDP1 4760/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.